SNPS
시놉시스
Source: dsi_quarterly · analyst_consensus (internal DB). DSI from quarterly filings; consensus as of collection.
Suppliers
—
Synopsys
Customers
Competitors
Notes
Synopsys is one of the 'Big Three' EDA vendors alongside Cadence and Siemens EDA, with roughly 30%+ share of the global EDA market. The company is acquiring Ansys (announced January 2024, expected to close 2025) to expand into multiphysics simulation. Synopsys benefits structurally from rising chip design complexity at advanced nodes (3nm/2nm) and AI accelerator proliferation.
Synopsys filed an 8-K citing Item 8.01 (Other Material Events), a catch-all item used for material corporate developments that do not fall under more specific disclosure categories — this could include strategic announcements, legal settlements, regulatory actions, or other board-level events. Item 9.01 indicates supporting exhibits were attached. Full filing body not analyzed; description inferred from form + item codes. PMs should pull the actual exhibit to determine the nature and magnitude of the event before acting.
Synopsys filed an 8-K disclosing its quarterly results of operations (Item 2.02), with supporting financial exhibits (Item 9.01). As the leading EDA software vendor, SNPS earnings are a bellwether for semiconductor design-tool spending and R&D cycle health — directly relevant to fabless customers such as NVIDIA, AMD, and key ARM-based SoC designers. Full filing body not analyzed; description inferred from form + item codes.
Synopsys filed its 10-Q for the quarter ended July 31, 2026, covering revenue, operating margins, and backlog trends for the EDA software and IP licensing business. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for any commentary on AI-driven EDA demand, Ansys integration progress, and updated annual guidance given Synopsys's role as a critical upstream enabler for advanced-node chip design.
Synopsys filed an 8-K under Item 5.02 reporting a change to its officer or director lineup — typically a departure, appointment, or role transition at the C-suite or board level. Without knowing the specific individual, PMs should check whether a key executive (CEO, CFO, or CTO) is affected, as that would elevate materiality; routine board additions or departures are unlikely to move the stock. Full filing body not analyzed; description inferred from form + item codes.
Full filing body not analyzed; description inferred from form + item codes. Synopsys disclosed a material definitive agreement (1.01), an officer/director change (5.02), and a Regulation FD communication (7.01) — the combination suggests a strategic action (potentially tied to the Ansys integration or financing) paired with leadership realignment and possibly updated forward commentary. PMs should check whether 7.01 contains revised guidance and whether 5.02 involves a top executive (CEO/CFO), as either would materially shift the thesis.
Filing under Item 2.02 indicates Synopsys issued its quarterly results, with Item 9.01 covering the accompanying press release exhibit. PMs should focus on EDA/IP revenue growth, design-start trends tied to AI silicon demand, and any update to FY guidance post-Ansys integration. Full filing body not analyzed; description inferred from form + item codes.
Quarterly filing covering the period ended 2026-04-30, likely containing EDA/IP revenue, design-services backlog, and any early commentary on the Ansys acquisition integration. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for China export-control exposure, AI/HPC design-start commentary, and FY26 guidance updates.
Filing combines Item 5.02 (officer/director changes), Item 5.07 (shareholder vote results, typically annual meeting outcomes), and supporting exhibits (9.01). Full filing body not analyzed; description inferred from form + item codes. PM relevance is limited unless 5.02 involves a CEO/CFO transition — otherwise treat as routine governance housekeeping around the annual meeting.
Synopsys filed an 8-K under Item 8.01 (Other Material Events) with supporting exhibits under Item 9.01. Item 8.01 is a catch-all used for voluntary disclosures the company deems material — could range from litigation updates to deal-related communications or regulatory matters tied to the pending Ansys transaction. Full filing body not analyzed; description inferred from form + item codes — PMs holding SNPS or trading the Ansys arb spread should pull the exhibit before sizing.
Synopsys filed its Q1 FY26 10-Q covering the quarter ended Jan 31, 2026 — the first reporting period likely consolidating the Ansys acquisition, making segment mix, deferred-revenue trends, and updated FY26 guidance the key items for PMs tracking EDA/semi-design exposure. Full filing body not analyzed; description inferred from form + item codes.
8-K covers Item 2.02 (earnings results) with 8.01 other material disclosure and 9.01 supporting exhibits, indicating Synopsys posted quarterly results and likely updated guidance. PMs should watch EDA/IP segment growth, design-start trends tied to AI chip demand, and any color on the Ansys integration. Full filing body not analyzed; description inferred from form + item codes.
8-K combines a Regulation FD disclosure (Item 7.01) — typically updated forward commentary or management remarks — with an officer/director change (Item 5.02). PM relevance hinges on whether 7.01 contains new guidance or color on the Ansys integration, EDA demand, and China exposure, and on the seniority of the personnel change. Full filing body not analyzed; description inferred from form + item codes.
Annual report covering Synopsys's FY2025 (ended 2025-10-31), the first full year reflecting the Ansys acquisition closure and integration. PMs should focus on EDA/IP segment growth, AI-design tool traction with TSMC/Samsung/hyperscaler customers, China export-control exposure, and FY2026 guidance — all key reads for the KR/TW semi supply chain. Full filing body not analyzed; description inferred from form + item codes.
8-K under Items 2.02 and 9.01 indicates Synopsys issued its quarterly/annual earnings release with accompanying exhibits (likely press release and financial tables). PMs should focus on EDA revenue growth, AI-driven design tool demand, Ansys deal integration commentary, and FY26 guidance versus consensus. Full filing body not analyzed; description inferred from form + item codes.
Combination of Reg FD forward guidance/commentary (Item 7.01) and an unregistered equity sale (Item 3.02) with supporting exhibits — likely tied to financing or M&A consideration (plausibly Ansys-related closing mechanics) paired with refreshed outlook commentary. Full filing body not analyzed; description inferred from form + item codes. PMs should check the exhibits for guidance deltas and dilution/issuance size before reacting.